Suma M. Krishnan
Net Worth
Last updated:
What is Suma M. Krishnan net worth?
The estimated net worth of Ms. Suma M. Krishnan is at least $297,754,206 as of 13 Dec 2024. She owns shares worth $212,467,973 as insider, has earned $81,028,073 from insider trading and has received compensation worth at least $4,258,160 in Krystal Biotech, Inc..
What is the salary of Suma M. Krishnan?
Ms. Suma M. Krishnan salary is $532,270 per year as Founder, Chief Operating Officer & Director in Krystal Biotech, Inc..
How old is Suma M. Krishnan?
Ms. Suma M. Krishnan is 60 years old, born in 1965.
What stocks does Suma M. Krishnan currently own?
As insider, Ms. Suma M. Krishnan owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | Founder, Chief Operating Officer & Director | 1,475,882 | $143.96 | $212,467,973 |
What does Krystal Biotech, Inc. do?
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.
Suma M. Krishnan insider trading
Krystal Biotech, Inc.
Ms. Suma M. Krishnan has made 142 insider trades between 2017-2024, according to the Form 4 filled with the SEC. Most recently she sold 923 units of KRYS stock worth $154,074 on 13 Dec 2024.
The largest trade she's ever made was exercising 100,000 units of KRYS stock on 22 Sep 2017. As of 13 Dec 2024 she still owns at least 1,475,882 units of KRYS stock.
Krystal Biotech key executives
Krystal Biotech, Inc. executives and other stock owners filed with the SEC:
- Mr. Krish S. Krishnan (60) Chairman, Pres & Chief Executive Officer
- Ms. Kathryn A. Romano (44) Chief Accounting Officer
- Ms. Suma M. Krishnan (60) Founder, Chief Operating Officer & Director